Gene Expression Analysis of the mTOR Pathway: Association with Radiation Therapy–Related Fatigue
Vol. 45 No. 3 (2026), Full-Length Articles
Vol. 45 No. 3 (2026)

Gene Expression Analysis of the mTOR Pathway: Association with Radiation Therapy–Related Fatigue: mTOR pathway, radiation therapy-related fatigue, prostate cancer

Full-Length Articles
Published 2026-09-24
Velda J. González-Mercado
New York University
Raul D. Bernabe-Dones
PDF

Keywords

Cancer-related fatigue
mTOR signaling
Radiation therapy
Gene expression
Translational regulation

How to Cite

González-Mercado, V. J., & Bernabe-Dones, R. D. (2026). Gene Expression Analysis of the mTOR Pathway: Association with Radiation Therapy–Related Fatigue: mTOR pathway, radiation therapy-related fatigue, prostate cancer. Puerto Rico Health Sciences Journal, 45(3), 172–177. Retrieved from https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/3861
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Objective: To examine whether changes in the expression of 40 preselected mammalian target of rapamycin complex 1 (mTOR) pathway–related genes were associated with changes in fatigue scores during external beam radiation therapy (EBRT) to treat prostate cancer. Methods: A total of 26 men completed the Functional Assessment of Cancer Therapy–Fatigue subscale and provided whole blood samples at baseline and at the midpoint of EBRT. Microarray gene expression data were analyzed using the limma package in R. Associations between changes in gene expression and changes in fatigue scores were computed using linear models and empirical Bayes moderation, with adjustment for radiation fraction. Results: After adjusting for radiation fraction, changes in the expression of 24 of 40 preselected genes were significantly associated with changes in fatigue during EBRT (false discovery rate < .05). Conclusion: Findings suggest that mTOR-related genes may play a role in radiation therapy–related fatigue; validation of these implicated genes in an independent cohort is warranted.

PDF
Authors who publish with this journal agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).